SCHEMBL6287572

SCHEMBL6287572

C=CC(O)CCCCC(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
ABCC4 O15439 1/20 0.50
MAPT P10636 1/20 0.50
FFAR4 Q5NUL3 1/20 0.48
FFAR1 O14842 1/20 0.48
TSHR P16473 2/20 0.48
NFKB1 P19838 2/20 0.48
SLC6A2 P23975 1/20 0.48
SLC6A4 P31645 1/20 0.48
BLM P54132 1/20 0.48
SLC6A3 Q01959 1/20 0.48
MEN1 O00255 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
KMT2A Q03164 1/20 0.48
PMP22 Q01453 1/20 0.48
GSTK1 Q9Y2Q3 2/20 0.47
ENPEP Q07075 1/20 0.45
PPARG P37231 2/20 0.44
GPR132 Q9UNW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10404891 0.98 ABCC4 (0.54) LMNAABCC4MAPTFFAR4FFAR1
SCHEMBL10280473 0.98 ABCC4 (0.54) LMNAABCC4MAPTFFAR4FFAR1
SCHEMBL7113665 0.98 ABCC4 (0.54) LMNAABCC4MAPTFFAR4FFAR1
SCHEMBL30969111 0.93 NFKB1 (0.50) LMNAABCC4MAPTTSHRNFKB1
SCHEMBL14883227 0.89 FFAR1 (0.56) LMNAABCC4MAPTFFAR4FFAR1
Dimethylamine SCHEMBL28092926 0.85 NFKB1 (0.44) LMNAABCC4MAPTFFAR4FFAR1
SCHEMBL28623051 0.83
SCHEMBL5437330 0.83 TRPA1 (0.34) MAPTTSHRNFKB1SLC6A2SLC6A4
SCHEMBL8994356 0.82 GSTK1 (0.36) ABCC4MAPTFFAR4FFAR1TSHR
Propylamine SCHEMBL28093163 0.81 FFAR4 (0.44) LMNAMAPTFFAR4FFAR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078215-A1 SIGMATROPIC REARRANGEMENTS OF POLYMER BACKBONES UNIV NORTH CAROLINA CHAPEL HILL (US) 2026-03-19 US disclosed
US-12503550-B2 Sigmatropic rearrangements of polymer backbones THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2025-12-23 US disclosed
US-20250002644-A1 SIGMATROPIC REARRANGEMENTS OF POLYMER BACKBONES THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2025-01-02 US disclosed
WO-2023086289-A1 SIGMATROPIC REARRANGEMENTS OF POLYMER BACKBONES THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2023-05-19 WO disclosed
US-6864287-B1 Derivatives of dicarboxylic acid having pharmaceutical properties BAYER AKTIENGESELLSCHAFT (DE) 2005-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078215-A1 SIGMATROPIC REARRANGEMENTS OF POLYMER BACKBONES SIGMAR1, TRRAP, PIK3R4 LMNA 3528/4885ABCC4 447/4885MAPT 2633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.